MHCC   Commissioners  

The Commission is composed of fifteen members appointed by the Governor, with the advice and consent of the Senate, for a term of four years. A short biography of each Commission member follows:

Andrew N. Pollak, MD, Chairman, earned his MD at Northwestern University School of Medicine. His internship in general surgery and residency in orthopaedic surgery were accomplished at the integrated Case Western Reserve University/University Hospitals of Cleveland Program. He went on to complete a fellowship in orthopaedic traumatology at University of California Davis Medical Center. Dr. Pollak is The James Lawrence Kernan Professor of Orthopaedics and Chair of the Department of Orthopaedics within the School of Medicine. He also serves as Chief of Orthopaedics for the University of Maryland Medical System. In the past, Dr. Pollak has served as Chair of the Board of Specialty Societies for the American Academy of Orthopaedic Surgeons (AAOS). He currently serves as Treasurer of the AAOS and is Past President of the Orthopaedic Trauma Association. Dr. Pollak is a former Chair of the Extremity War Injuries Project Team for the AAOS, previously served as a Commissioner for the Maryland Health Care Commission from 2004-2008, and is a former Past President of the Maryland Orthopaedic Association. His current responsibilities include Executive Committee Co-Chair for the Major Extremity Trauma Research Consortium (METRC), Chair of the Publications Committee for METRC, Editor of the AAOS Orange Book Series, Medical Director of the Baltimore County Fire Department, and Special Deputy US Marshal. (Term Expires 9/30/2024)

Randolph S. Sergent, Esq, Vice Chairman, is Vice President and Deputy General Counsel for CareFirst BlueCross BlueShield, where he has been employed since 2010. Prior to joining CareFirst, Mr. Sergent was a partner at Venable, LLP. Mr. Sergent also has served in the Maryland Attorney General’s Office as Deputy Counsel to the Maryland Insurance Commissioner and as Assistant Attorney General in Civil Litigation Division. Mr. Sergent is a member of the Ethics Committee of the Maryland State Bar Association, and has served as Chair of the MSBA’s Health Law Section. Mr. Sergent holds a Juris Doctorate from the University of Virginia School of Law, a Master of Science in Electrical Engineering from the University of Maryland, College Park, and a Bachelor of Science in Electrical Engineering from the University of Virginia. Mr. Sergent resides in Howard County. (Term Expires 9/30/2024)

Bimbola Akintade, PhD, earned a bachelor's, master's, and doctoral degree at the University of Maryland School of Nursing. In addition, he earned an MBA and MHA from the University of Maryland University College. He is an Associate Professor and Associate Dean for the Master’s Specialties at the University of Maryland School of Nursing. He is a Fellow of the American Association of Nurse Practitioners and currently practices as an Acute Care Nurse Practitioner in the Post Anesthesia Care Unit at the University of Maryland Medical Center and the Trauma/Surgical Intensive Care Unit at the University of Maryland Capital Region Medical Center. He is a pioneer Board Member, Research Committee Chair and Finance Committee Member of the Doctors of Nursing Practice of Color. (Term Expires 9/30/2022)

Arun Bhandari, MD, is a practicing Oncologist and Hematologist at Chesapeake Oncology Hematology Associates, PA (COHA), Annapolis, MD since 2007(an Oncology - Hematology private practice serving citizens of Maryland since 1990). He is on staff at Anne Arundel Medical Center (AAMC), Baltimore Washington Medical Center (BWMC) and John Hopkins Medicine at Howard County General Hospital (HCGH). Dr. Bhandari is an Executive Board Member of The Maryland and District of Columbia Society Of Clinical Oncology, Inc. (MDCSCO) which plays a significant role to improve the quality and delivery of cancer care in Maryland and the District of Columbia.

Bhandari was appointed by Governor Hogan as a Council on the Maryland State Council on Cancer Control, where he has a role to educate and advise government officials, public and private organizations and the general public on comprehensive State policies and programs necessary to reduce and control cancer incidence, mortality and morbidity among Marylanders. Dr. Bhandari served as a member of the Maryland Board of Physicians from 2016 to 2020. He served as Chairman of Panel A of the Board from May 2016 until April 2020, where he was responsible to assure quality health care in Maryland through the efficient licensure and effective discipline of healthcare providers under its jurisdiction by protecting and educating clients, customers and stakeholders, and enforcing the Maryland Medical Practice Act.

Dr. Bhandari completed fellowship in Hematology-Oncology from Georgetown University Hospital/Washington Hospital Center, Washington, DC with bone marrow transplant rotation at the National Institute of Health (NIH- NHLBI), Bethesda, MD. He served as a Chief fellow in Hematology & Oncology from 2004-2005. He was a fellow in Hematology & Oncology at The University of Tennessee Health Science Center, Memphis, TN, and NCCN Member Institution. (Term Expires 9/30/2025)

Cassandra Boyer, BA,  works at the US. Army Communications Electronics Command (CECOM) at the Aberdeen Proving Ground, MD. She currently serves as the point person coordinating the Software Engineering Center’s Human Capital Program. Past roles have included Executive Officer, Corporate Communications and the CECOM Commander’s Initiatives Group. Prior to her employment with the US Army, Ms. Tomarchio held several positions in public affairs including as Director of Communications for Coventry Health Care of Delaware and Director of Advocacy for the American Lung Association. Ms. Tomarchio lives in Havre de Grace, MD and serves her community as a member of the Havre de Grace City Council. She is a graduate of Ursinus College with additional study at Johns Hopkins University and the College of Notre Dame. (Term Expires 9/30/2023)

Marcia L. Boyle, MS, is the founder of the Immune Deficiency Foundation (IDF), the national non-profit patient organization dedicated to improving the diagnosis, treatment and quality of life of persons with primary immunodeficiency diseases through advocacy, education and research (www.primaryimmune.org.) She served as president and CEO until her retirement in August, 2017. She grew IDF from 5 volunteers in 1980 to an organization with approximately $10 million a year in revenue in 2017 and a full time staff of 37. She was a co-founder of the International Patient Organization for Primary Immunodeficiencies (IPOPI), which currently includes representation of patient organizations from 60 countries around the world. She also served on the Board of Directors of the National Health Council from 2015 to 2017. She was honored as a White House Champion of Change in Precision Medicine in 2015. (Term Expires 9/30/2022)

Trupti Brahmbhatt, PhD, is a Senior Policy Researcher at Rand. Trupti has earned a Bachelor of Science in Zoology (with Botany and Chemistry Minor) and a Master in Microbiology; a Doctor of Philosophy degree in Emerging Infectious Diseases; a Master of Arts degree in Diplomacy (terrorism track) an Executive Master of Business Administration (defense acquisition); and a Master in Science and Technology Intelligence (cyber security and data analytics). Trupti is an American Society of Clinical Pathology board certified technologist in Microbiology and Immunology; International Acquisition level III trained, and Science and Technology Manager level III certified at National Acquisition University and a Black Belt, Lean Six Sigma. Trupti enlisted in the United States Navy in 1990 She retired from the Navy in 2018 after 28 years of active duty service. Trupti holds an appointment as an Assistant Adjunct Professor at the Department of Microbiology and Immunology, School of Medicine, Uniformed Services University, Maryland. Dr. Brahmbhatt's professional interest and expertise includes healthcare policy, science and technology, strategic planning, intelligence, defense acquisition, infectious diseases, microbiology, and biodefense. (Term Expires 9/30/2023)

Martin L. "Chip" Doordan, MHA, earned a Master of Arts in Health Care Administration from George Washington University, a Master of Science from the University of Maryland, and a Bachelor of Science from Univ. of Delaware. He has held positions in health care delivery for his entire career. Chip served as CEO and President of Anne Arundel Medical from 1994 to 2011 and as President from 1988 through 1994. He also, directed the growth of AAMC from a community hospital to by 2011 a regional medical center with over 3,200 employees and an annual budget of over $550 million. He served in the US Army from 1968 to 1971, including service in Vietnam from 1970-1971. (Term Expires 9/30/2022)

Jeffrey Metz, MBA, LNHA, is President and Administrator of Egle Nursing and Rehab Center located in Lonaconing, Maryland. He is also a founding partner in Foundation, Rehab, an affiliate of Egle that provides long term care rehabilitation services., Mr. Metz previously served as Vice-Chair for the Maryland State Board of Examiners of Nursing Home Administrators. A graduate of Frostburg State University, he has a Bachelors of Science degree in Accounting and also a Master's Degree in Business Administration. Mr. Metz resides in Allegany County. (Term Expires 9/30/2022)

Gerard S. O'Connor, MD, is a surgeon in private practice in Chestertown Maryland. In addition to his private practice, Dr. O'Connor has served as Chief of the Medical Staff and Chief of Surgery at Chester River Hospital Center now University of Maryland Shore Medical Center at Chestertown. Dr. O'Connor received his undergraduate medical education at Georgetown University and completed a residency in general surgery at George Washington University. Dr. O'Connor will bring to the Commission the perspective of a physician that serves a rural Maryland community. (Term Expires 9/30/2023)

Michael J. O'Grady, Ph.D a Principal of O'Grady Health Policy LLC, a private health consulting firm and a Senior Fellow at NORC at the University of Chicago. His current research is concentrated on the interaction between scientific development and health economics, with a particular concentration on diabetes and obesity.

From 2003 to 2005, he was the assistant Secretary for Planning and Evaluation (ASPE) at HHS. Dr. O'Grady worked directly with the Secretary on such critical policy issues as implementing the new Medicare drug benefit. Prior to his Senate confirmation as the Assistant Secretary, he served as a senior health advisor to the Chairman of the Senate Finance Committee and a senior health economist at the Joint Economic Committee of the U.S. Congress. Dr. O'Grady also held senior staff positions with the Medicare Payment Advisory Commission and the Congressional Research Service (CRS) at the Library of Congress.

Dr. O'Grady also serves on a number of Commissions and Boards including the National Committee on Vital and Health Statistics (NCVHS) and the Board of Directors of the Patient Access Network and Academy Health. He received his PhD. in political science from the University of Rochester. Commissioner O'Grady resides in Montgomery County. (Term Expires 9/30/2023) 

Martha G. Rymer, CPA, is the partner/ owner of Rymer & Associates PA., located in Calvert County Maryland. She has been a professional in the practice since 1998. Prior to joining the practice she was the Chief Financial Officer at Calvert Memorial Hospital for 13 years. Martha has brought to the practice her extensive knowledge of health care. In addition, Martha works with a wide variety of business clients in the construction, printing, real estate, restaurant and retail industries. In addition to tax preparation, she also consults on business practice management issues and assists various businesses with analysis of financial performance and planning. In addition to her responsibilities running her business, she is the Treasurer of her local Chamber of Commerce and on the finance committee of the local hospice and her church. Martha graduated from Mount Saint Mary’s University in 1983 with a BS degree in Accounting. She is a certified public accountant licensed in the State of Maryland. (Term Expires 9/30/2025) 

Marcus L. Wang, Esq. is a Harvard-educated CEO and New York-licensed attorney with proven experience both in building startups to profitability and in expanding public companies globally. He has powered companies to success in diverse sectors ranging from biotech and genomics to retail and e-commerce, in both the U.S. and China.

Mr. Wang serves as Co-Founder, President and General Manager of ZytoGen Global Genetics Institute, which utilizes Next Generation Sequencing to drive successful pregnancy outcomes for patients worldwide through its proprietary Preimplantation Genetic Screening platform. Mr. Wang’s international business and legal experience covers both the U.S., where he practiced corporate law at the Manhattan office of DLA Piper, as well as China, where he spearheaded the development, execution and launch of Under Armour’s China market entry in 2011. Mr. Wang continues to advise U.S. businesses concerning China market entry and partnerships, providing guidance on go-to-market strategy, regulatory issues, brand development, and product localization.

Mr. Wang also serves as the Chair of the Baltimore County Economic Development Advisory Board. Formed in 2020 by Baltimore County Executive Johnny Olszewski, the Board is tasked with advising the administration on strategies for attraction and retention of businesses, best practices for public-private partnerships, and the creation of a long-term economic development strategy.

Born and raised in Baltimore, Mr. Wang is a graduate of Gilman School with an A.B. cum laude from Harvard University and a J.D. from the University of Maryland Francis King Carey School of Law. Mr. Wang also holds a Certificate in International and Comparative Business Law from the Central University of Finance and Economics in Beijing, and a Certificate in Genetics and Genomics from Stanford University. Mr. Wang is licensed and admitted to practice as an attorney in the State of New York. (Term Expires 9/30/24)


Last Updated: 10/6/2021